Skip to main content

Table 1 Demographic and spirometric data of all participants

From: Cytokine profile in the sputum of subjects with post-tuberculosis airflow obstruction and in those with tobacco related chronic obstructive pulmonary disease

 

COPD/post-TB

COPD/tobacco

Control

p

Age

40 ± 2.1

63 ± 10.45

43 ± 12.38

0.0002

Male

16 (40%)

42 (84%)

40 (66.7%)

0.002

Female

24 (60%)

8 (16%)

20 (33.3%)

FEV1

53.30% (± 17.21%)

36.88% (± 14.95%)

83 ± 6.56%

<  0.0001

FVC

84.89 ± 15,1%

72.97 ± 14.5%

97.64 ± 4.15%

<  0.0001

FEV1/FVC

62.79% (± 17.95%)

50.54% (± 12.09%).

85 ± 6.06%

<  0.0001

Stage of disease

Stage I: 0

Stage I: 0

 

0.038

Stage II: 20 (50%)

Stage II: 11 (22%)

Stage III: 15 (37.5%)

Stage III: 14 (28%)

Stage IV: 5 (12.5%)

Stage IV: 25 (50%)

  1. FEV1 Forced expiratory volume in the first second, FVC Forced vital capacity, FEV1/FVC Forced expiratory volume/ forced vital capacity ratio